Live
- BJP MP candidate Bharat Prasad visited the student who tried to commit suicide
- PM’s popularity in the fast lane: Autos with 'Har Dil Mein Modi' slogan spotted across Delhi
- Delhi-based political parties are like East India Company: Sukhbir Badal
- Golf: Diksha moves into Top-20 at South African Women’s Open
- KCR lashes out against BJP and Congress for destroying Telangana
- Dairy Science students visited the Milk cooling plant
- Moody feels Pant ahead in keepers’ race for T20 WC squad; Srikkanth picks Rahul over Samson as reserve keeper
- Thanking voters for extending 'unparalleled support' to NDA, PM Modi says second phase 'too good'
- Natural Relief for Menstrual Cramps: Beetroot Juice Recipe
- Asha Worker died in a road accident
Macleods Pharma recalls diabetes drug in US
Macleods Pharma USA Inc is recalling 31,968 bottles of Pioglitazone Hydrochloride tablets used for treatment of diabetes in the American market.
New Delhi: Macleods Pharma USA Inc is recalling 31,968 bottles of Pioglitazone Hydrochloride tablets used for treatment of diabetes in the American market.
The tablets being recalled are in the strength of 15 mg and have been manufactured by Macleods Pharmaceuticals Ltd in its Baddi facility in Himachal Pradesh, an enforcement report of the USFDA said.
The voluntary ongoing class II recall is on account of the product being "superpotent'', it added.
The product was shipped to eight distributors who may have further distributed the product, the United States Food and Drug Administration (USFDA) said.
As per the USFDA, a class II recall is initiated in a situation, "in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote".
